NCT05188729 2025-06-18Open-Label Proof of Concept Study of VP-315 in Basal Cell CarcinomaVerrica Pharmaceuticals Inc.Phase 2 Completed92 enrolled 17 charts
NCT00847912 2021-06-11VAKCCTVA Office of Research and DevelopmentPhase 4 Completed954 enrolled 11 charts